01 Rising Prevalence of Painful ConditionsThe rising prevalence of painful conditions like arthritis, back pain, and diabetic neuropathy is a key driver of the topical pain relief market. As these chronic conditions become more widespread, so does the demand for effective pain management solutions. For instance, according to the Centers for Disease Control and Prevention (CDC), more than 58.5 million adults in the United States have arthritis. The CDC has projected that by 2040, approximately 35 million people will be affected by arthritis. This led to an acceleration of the market. Topical pain relievers offer a convenient and targeted approach, addressing this growing need.
02 Rising Prevalence of Painful ConditionsThe increased popularity of non-opioid pain medications is contributing to the growth of the topical pain reliever industry. Alternative solutions have been demanded by patients and healthcare professionals due to concerns over addiction, tolerance building, and other negative effects related to oral pain drugs, particularly opioids. Topical analgesics offer a focused method of relieving localized pain without the systemic side effects that are sometimes connected to oral drugs. The market for pain relievers currently has a large window of opportunity due to this shift in preferences.
01 Risk of Overuse and DependenceThe convenience of application of topical analgesics could pose limitations. Even though they are simple to use and provide focused relief, misuse may have unforeseen repercussions. For instance, over time, using substitutes containing anti-inflammatory medications may irritate the skin or maybe endanger renal function. Furthermore, certain components may develop an addiction when the body grows reliant on the drug to manage pain, creating a vicious cycle in which more and more of the substance is required to provide the same level of comfort. As patients deal with possible long-term negative effects, this might impede market expansion.
01 Increasing Technological AdvancementsThe market will benefit from technological advancements with the introduction of smart irrigation devices. App connectivity enables individualized cleaning routines based on dentist recommendations or user preferences. Pressure sensors and automatic closing functions increase user safety and comfort. Moreover, features such as in-built active water jet technology it also gaining traction. For instance, in August 2020, Panasonic Holdings Corporation launched a new portable ultrasonic topical pain relief EW1511 with built-in active water jet technology, five pressure levels and a unique cordless design. It also features a flexible nozzle ultrasonic water jet with tiny bubbles that remove food particles and remove bacteria from periodontal pockets and floating plaque that can cause gum disease. With around 1,600 pulses per minute, it also gently stimulates the gums.
02 Growing Focus on Oral Health AwarenessIncreasing oral health awareness and topical pain relief sales can be accomplished via collaborating with dentists. Manufacturers can leverage their reliable expertise to educate customers about the advantages of staying hydrated by collaborating with dental professionals and hygienists. This can be achieved via specific instructional materials provided in dental practices, in-office consultations, and cooperatively created marketing initiatives that highlight the ways in which irrigators supplement customary brushing and flossing to maintain gum health and oral hygiene. Patients become informed consumers who recognize the benefits of topical pain relief as a result of this strategic collaboration, which also increases trust and credibility.
July 2025 Haleon reported the continued rollout of Voltaren 24-hour Pain Relief Patch into additional European markets, including Portugal, Austria, and the UK, while introducing new patch formats and expanding systemic Voltadexibu in Germany and Italy to strengthen its pain management portfolio.
May 2025 Haleon expanded its topical pain relief portfolio by launching Voltaren 2% in China, targeting older adults with a long-lasting anti-inflammatory formulation, supporting the company's geographic expansion strategy in the pain relief segment.
May 2025 Haleon strengthened the Voltaren brand by activating its partnership as the official licensed pain relief brand of the UEFA Champions League, increasing brand visibility through in-store promotions and experiential marketing during the tournament final in Munich.